Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Walter Reed Army Medical Center University of Virginia James Madison University Eastern Virginia Medical School |
---|---|
Information provided by: | Walter Reed Army Medical Center |
ClinicalTrials.gov Identifier: | NCT00487643 |
Purpose: to build a library of normal tear lacritin values by collecting tears from normal adult human subjects and to develop a non-invasive clinical assay for lacritin. Such an assay will provide more sensitive indicators of eye disease for clinicians and determine if a particular therapy, such as recombinant lacritin drops, is of benefit.
Condition | Intervention |
---|---|
Tear Protein Lacritin in Human Tears |
Procedure: Tear Collection |
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay |
Ages Eligible for Study: | 21 Years to 55 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, District of Columbia | |
Walter Reed Army Medical Center | Recruiting |
WASHINGTON, District of Columbia, United States, 20307 | |
Contact: Kraig s. Bower, MD 202-782-0202 kraig.bower@na.amedd.army.mil | |
Principal Investigator: Kraig S. Bower, MD |
Principal Investigator: | Kraig S. Bower, MD | WRAMC |
Responsible Party: | Walter Reed Army Medical Center ( Kraig S. Bower, Study Principal Investigator ) |
Study ID Numbers: | WRAMC WU# 07-23021 |
Study First Received: | June 15, 2007 |
Last Updated: | March 31, 2008 |
ClinicalTrials.gov Identifier: | NCT00487643 |
Health Authority: | United States: Federal Government |
Lacritin |
Lacerations |